Tipsheet
What matters at India’s listed companies
BSE · Corporate Action · Medium

Anupam Rasayan's ₹299/share open offer for Bliss GVS Pharma opens July 28

Anupam Rasayan India Ltd, with PAC Mates Visa Consultancy, bids for up to 26% of Bliss GVS Pharma at ₹299/share. Offer window: July 28 – August 10, 2026.

24 Jul 2026 Effective 28 July 2026 Affects: Public shareholders of Bliss GVS Pharma Limited

What changed

  • Open offer for Bliss GVS Pharma shares opens July 28, 2026.
  • Offer price: ₹299 per share, cash, for 26% of expanded voting capital.
  • Acquirer: Anupam Rasayan India; PAC: Mates Visa Consultancy.

The read

BSE has set the timeline for Anupam Rasayan's takeover bid for Bliss GVS Pharma, with an offer price of ₹299 per share in cash covering up to 26% of expanded equity. Shareholders can tender from July 28 to August 10 — a standard two-week window. The decision is simple: compare ₹299 to the market price; if the offer is higher, tender; if lower, hold. No regulatory surprise; the exchange is simply running a routine SAST process.

Bliss GVS Pharma LimitedAnupam Rasayan India LimitedMates Visa Consultancy Private Limited₹299 per share

Primary source: official circular (PDF)